The IL-17 signaling pathway indirectly triggers the release of proinflammatory cytokines, including TNF and IL-6 [49], which subsequently activate the NF-κB pathway, thereby exacerbating inflammatory liver diseases and related pathological conditions [50]. The gene discussed is NFKB1; the disease is liver disorder.